A Look at GoodRx, Inari, and Amwell

In this episode of Industry Focus: Wildcard, host Dylan Lewis is joined by Motley Fool contributor Brian Feroldi to look at the results of GoodRx (NASDAQ: GDRX), Inari (NASDAQ: NARI), and Amwell (NYSE: AMWL) and check if they are still interesting enough for your watch list.

To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. To get started investing, check out our quick-start guide to investing in stocks. A full transcript follows the video.

Continue reading

Source Fool.com